Introduction. In recent years, determination of soluble transferrin receptor levels has been emerging as a test that can reliably indicate iron deficiency in various states, and that is non-invasive and easy to use. The aim of this study was: to determine reference values of soluble transferrin receptor concentrations in serums in our population, to examine the reliability of this method in the diagnosis of anemia due to iron deficiency and associated iron deficiency in anemia accompanying malignant hemopathies, and to identify possible limitations of the test in certain conditions.
Material and Methods. The prospective research included 86 patients with anemia: 46 patients with iron deficiency anemia, and 40 patients with malignant hemopathies. The control group consisted of 40 healthy persons aging over 18.
Results. Ferritin values were reduced in 76.1% of patients, while higher levels of soluble transferrin receptors appeared in 100% of patients with iron deficiency anemia. In patients with reduced serum ferritin levels, the soluble transferrin receptor/log ferritin index was statistically significantly higher than in patients in whom ferritin concentration was in the normal range (p <0.001). ROC analysis of patients with iron deficiency anemia showed that the soluble transferrin receptor/log ferritin index (AUC 0.977) and levels of soluble transferrin receptors (AUC 0.931) occupied the largest area under the curve. The best diagnostic parameter for detecting iron deficiency in patients with malignant hemopathies by ROC analysis is the soluble transferrin receptor/log ferritin index (AUC 0.770).
Conclusion. Soluble transferrin receptors are useful in the diagnosis of iron deficiency anemia, especially when ferritin values are not reduced. The calculation of soluble transferrin receptor/log ferritin index is even more reliable. In patients with malignant hemopathies, the associated iron deficiency could be best indicated by soluble transferrin receptor/log ferritin index.
1. Clark SF. Iron deficiency anemia: Diagnosis and management. Curr Opin Gastroenterol 2009;25(2):122-8. DOI: 10.1097/MOG.0b013e32831ef1cd
2. Nissenson AR, Goodnough LT, Dubois RW. Anaemia: not just an innocent bystander? Arch Intern Med. 2003;163(12):1400-4. DOI: 10.1001/ archinte.163.12.1400
3. Black M.M. Integrated strategies needed to prevent iron deficiency and to promote early child development. J Trace Elem Med Biol. 2012 Jun;26(2-3):120-3. DOI: 10.1016/j.jtemb.2012.04.020
4. Sennels HP, Jørgensen HL, Hansen AL, Goetze JP, Fahrenkrug J. Diurnal variation of hematology parameters in healthy young males: the Bispebjerg study of diurnal variations. Scand J Clin Lab Invest. 2011 Nov;71(7):532-41. DOI: 10.3109/00365513.2011.602422
5. Oustamanolakis P, Koutroubakis IE, Kouroumalis EA. Diagnosing anemia in inflammatory bowel disease: beyond the established markers. J Crohns Colitis. 2011 Oct;5(5):381-91. DOI: 10.1016/j.crohns.2011.03.010
6. Lipschitz DA, Cook JD, Finch CA: A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med. 1974;290(22):1213-6. DOI: 10.1056/ NEJM197405302902201
7. Goddard AF, James MW, McIntyre AS, Scott BB. Guidelines for the management of iron deficiency anaemia. Gut. 2000;46(suppl 3-4):IV1-IV5.
8. Nadeem S, Shah S, Iqbal T, Iqbal Z, Hanif E. Serum transferrin receptor, serum ferritin and serum transferrin receptor-ferritin index in adults with iron deficiency anaemia. J Ayub Med Coll Abbottabad. 2011 Jul- Sep;23(3):44-6.
9. Berlin T, Meyer A, Rotman-Pikielny P, Natur A, Levy Y. Soluble transferrin receptor as a diagnostic laboratory test for detection of iron deficiency anemia in acute illness of hospitalized patients. IMAJ. 2011; 13: 96-8.
11. Das Gupta A, Abbi A. High serum transferrin receptor level in anemia of chronic disorders indicates coexistent iron deficiency. Am J Hematol. 2003;72(3):158-61. DOI: 10.1002/ajh.10260
12. Mast AE, Blinder MA, Gronowski AM, Chumley C, Scott MG. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem. 1998;44(1):45-51.
13. Braga F, Infusino I, Dolci A, Panteghini M. Soluble transferrin receptor in complicated anemia. Clin Chim Acta. 2014;431:143-7. DOI: 10.1016/j.cca.2014.02.005
14. Metzgeroth G, Kripp M, Müller N, Schultheis B, Bonatz K, Walz C, et al. The soluble transferrin receptor (TfR)-F-Index is not applicable as a test for iron status in patients with chronic lymphocytic leukemia. Clin Chem Lab Med. 2009;47(10);1291-5. DOI: 10.1515/ CCLM.2009.273
15. Allen J, Backstrom KR, Cooper JA, Cooper MC, Detwiler TC, Essex DW, et al. Measurement of soluble transferrin receptor in serum of healthy adults. Clin Chem. 1998;44(1):35-9.
16. Van den Bosch G, Van den Bossche J, Wagner C, De Schouwer P, Van De Vyvere M, Neels H. Determination of iron metabolism-related reference values in a healthy adult population. Clin Chem. 2001;47(8):1465-7.
17. Kolbe-Busch S, Lotz J, Hafner G, Blanckaert NJC, Claeys G, Togni G, et al. Multicenter evaluation of a fully mechanised soluble transferrin receptor assay on the Hitachi and Cobas Integra analyzers. The determination of reference ranges. Clin Chem Lab Med. 2002;40(5): 529-36. DOI: 10.1515/CCLM.2002.091
18. Lee EJ, Oh EJ, Park YJ, Lee HK, Kim BK. Soluble transferrin receptor (sTfR), ferritin and sTfR/log ferritin index in anemic patients with nonhematologic malignancy and chronic inflammation. Clin Chem. 2002;48(7):1118-21.
19. Skikne BS, Punnonen K, Caldron PH, Bennett MT, Rehu M, Gasior GH, et al. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index. Am J Hematol. 2011;86(11):923-7. DOI: 10.1002/ ajh.22108
20. Castel R, Tax MG, Droogendijk J, Leers MP, Beukers R, Levin MD, et al. The transferrin/log (ferritin) ratio: a new tool for the diagnosis of iron deficiency anemia. Clin Chem Lab Med. 2012;50(8):1343-9. DOI: 10.1515/cclm-2011-0594
21. Karlsson T. Comparative Evaluation of the Reticulocyte Hemoglobin Content Assay When Screening for Iron Deficiency in Elderly Anemic Patients. Anemia. 2011; Article ID 925907, 3 pages. DOI: 10.1155/2011/925907
22. Asobayire FS, Adou P, Davidsson L, Cook JD, Hurrell RF. Prevalence of iron deficiency with and without concurrent anemia in population groups with high prevalences of malaria and other infections: a study in Cote d’Ivore. Am J Clin Nutr. 2001;74(6):776-82.
23. Ferguson BJ, Skikne BS, Simpson KM, Baynes RD, Cook JD. Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia. J Lab Clin Med. 1992;119(4):385-90.
24. Takubo T, Kumura T, Nakao T, Nakamae H, Aoyama Y, Nishiki S, et al. Clinical usefulness of combined measurements of serum soluble transferrin receptor levels and serum interleukin-18 levels at determination of serum KL-6 levels in haematologic malignancies. Acta Haematol. 2000;104(2-3):141-3. DOI: 10.1159/000039750
25. Brada SJ, de Wolf JT, Hendriks D, Louwes H, van den Berg E, Vellenga E. Characterization of the erythropoiesis in myelodysplasia by means of ferrokinetic studies, in vitro erythroid colony formation and soluble transferrin receptor. Leukemia. 1998;12(3):340-5. DOI: 10.1038/sj.leu.2400961
26. Stasi R, Zinzani L, Galieni P, Lauta VM, Damasio E, Dispensa E,, et al. Clinical implications of cytokine and soluble receptor measurements in patients with newly-diagnosed aggressive non-Hodgkin’s lymphoma. Eur J Haematol. 1995;54(1):9-17. DOI: 10.1111/ j.1600-0609.1995.tb01619.x
27. Dalal H, Samia A, Hadir EM, Nahla AB, Inas EA. Serum transferrin receptor in relation to iron status in different disease stages of adult malignant lymphoma. Journal of the Egyptian Nat. Cancer Inst. 2002;14(3):237-42.
28. Munoz M, Villar I, Garcia-Erce JA. An update on iron physiology. World J Gastroenterol. 2009;15(37):4617-26. DOI: 10.3748/wjg.15.4617
29. Ferrari M, Mistura L, Patterson E, Sjöström M, Díaz LE, Stehle P, et al. Evaluation of iron status in European adolescents through biochemical iron indicators: the HELENA Study. Eur J Clin Nutr. 2011;65(3):340-9. DOI: 10.1038/ejcn.2010.279